Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial

Simple item page
dc.contributor.authorNiyomnaitham S.
dc.contributor.authorToh Z.Q.
dc.contributor.authorLicciardi P.V.
dc.contributor.authorWongprompitak P.
dc.contributor.authorSrisutthisamphan K.
dc.contributor.authorCopeland K.K.
dc.contributor.authorChokephaibulkit K.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:43:03Z
dc.date.available2023-06-18T17:43:03Z
dc.date.issued2022-10-01
dc.identifier.citationJournal of Infection Vol.85 No.4 (2022) , 436-480
dc.identifier.doi10.1016/j.jinf.2022.06.014
dc.identifier.eissn15322742
dc.identifier.issn01634453
dc.identifier.pmid35728642
dc.identifier.scopus2-s2.0-85137277797
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/85499
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleImmunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85137277797&origin=inward
oaire.citation.endPage480
oaire.citation.issue4
oaire.citation.startPage436
oaire.citation.titleJournal of Infection
oaire.citation.volume85
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationUniversity of Melbourne
oairecerif.author.affiliationMahidol University
oairecerif.author.affiliationThailand National Center for Genetic Engineering and Biotechnology
oairecerif.author.affiliationMurdoch Children's Research Institute

Files

Collections

Scopus 2022